Chartrel N C, Clabaut M T, Boismare F A, Schrub J C
Laboratory of Feto-Maternal Physiopathology, Faculty of Sciences, University of Rouen, Mont-Saint-Aignan, France.
Diabetes. 1990 Jun;39(6):743-6. doi: 10.2337/diabetes.39.6.743.
This study examined the relationship between uteroplacental blood flow and fetal hypotrophy in streptozocin-induced diabetic rats (40 mg/kg body wt i.v.). Our results showed that, in diabetic rats, fetal hypotrophy was associated with a significant reduction in arterial blood velocity in the uterine artery (P less than 0.001), placenta (P less than 0.01), umbilical artery (P less than 0.01), and fetal aorta (P less than 0.05). This was not observed when diabetic rats were treated with insulin. Treatment of rats with the alpha 1-blocking vasodilator nicergoline restored fetal growth and arterial blood velocity to control values without affecting the degree of hyperglycemia. Nicergoline in control rats did not change fetal weight and caused only minor hemodynamic changes on presumably already maximally vasodilated arteries. We concluded that the uteroplacental hemodynamic disturbances observed in diabetic rats play a major role in the establishment of fetal growth retardation.
本研究检测了链脲佐菌素诱导的糖尿病大鼠(静脉注射40mg/kg体重)子宫胎盘血流与胎儿发育迟缓之间的关系。我们的结果显示,在糖尿病大鼠中,胎儿发育迟缓与子宫动脉(P<0.001)、胎盘(P<0.01)、脐动脉(P<0.01)和胎儿主动脉(P<0.05)的动脉血流速度显著降低有关。用胰岛素治疗糖尿病大鼠时未观察到这种情况。用α1-阻断血管扩张剂尼麦角林治疗大鼠可使胎儿生长和动脉血流速度恢复至对照值,而不影响高血糖程度。对照大鼠使用尼麦角林不会改变胎儿体重,并且对可能已处于最大血管扩张状态的动脉仅引起轻微的血流动力学变化。我们得出结论,糖尿病大鼠中观察到的子宫胎盘血流动力学紊乱在胎儿生长迟缓的发生中起主要作用。